Body Fluid Homeostasis Flashcards
vasopressin
antidiuretic hormone, ADH
released from posterior pituitary gland
made in cell body of neurons, travels down axon and stored in vesicles
when ap generated in neurosecretory neurons, ap caused fusion of vesicles containing vasopressin to membrane and it be released
diffuses into circulation in venous blood supply
target organ = kidney
vasopressin function
regulates body fluid osmolality (con of body fluid), conserves H2O
inc body fluid = inc vasopressin = conserves water, more water in plasma, conc plasma dec in osmolality
dec osmolality = inc vasopressin, excrete higher urine flow rate, plasma becomes more conc
hypothalmic receptors
sensitive to conc changes in plasma
detect change of +/- 3 mosmol/kg H2O
supraoptic and periventricular nuclei regions of hypothalamus
stimulation of osmoreceptors - leads to action potnetial (inc osmolality)
a) release vasopressin from posterior pituitary
b) feeling of thirst
regulation of release
increase
inc release = inc osmol of plasma = inc water retention
solute ingestion or H2O deficiency
stress and drugs - nictoine and ecstasy
regulation of release
decrease
dec release = dec osmol in plasma
excessive fluid ingestion
alcohol - inhibits release of vasopressin, excrete more water - dehydration
principle cell H2O model
vasopressin in peritubular capillaries
diffuses into interstitial fluid, binds to vasopressin receptor (V2)
activation of V2 activates signalling molecule - protein kinase A = mediates phosphorylation which leads to insertion of vesicles under apical mem and fuse
AQP2 in vesicle mem = now in apical membrane as vesicles fuse
inc vaso = inc AQP2 = inc water reab
when vaso dec, AQP channels are pulled out of membrane
net effect of vasopressin
increased vaso = inc H2O reab = dec body fluid osmolality
diabetes insipidus
problems with AQP2, vasopressin and H2O reab
copious quantities of dilute urine - 23L/day = dehydration
central diabetes = no release of vaso - treatment = nasal spray DDAVP = synthetic vasopressin
nephrogenic diabetes = defect at level of kidney = no response to vaso, defect in V2 receptor = cant bind vaso or activate cAMP and protein kinase A or defect in AQP2 channel - range of treatments
aldosterone
released from cortex of adrenal gland - zona glomerulosa layer
classed as mineralocorticoid, regulates plasma Na, K and body fluid vol
released in response to: inc plasma K, dec plasma Na, dec ECF vol
acts on late distal tubule and collecting duct on both principle and IC cells
causes - inc reab Na so inc reab H2O, inc secretion K and H
principle cell genomic action
aldosterone = mem soluble, can pass through bilayer, diffuses into cell
mineralocortidcoid receptor inside cell is bound by aldosterone
this complex moves to nucleus, stimulates RNA transcription and protein synthesis = genomic action
e.g. promotes production of ENaC, ROMK and NaH exchanger
slow action
alpha IC cell genomic action
inc protein synthesis for ATP/H pump to allow cell to secrete more H into tubular fluid into urine
net effect in principle and IC cell
inc plasma Na so inc ECF vol, dec plasma K, dec plasma H
co-ordinate regulation with renin-angiotensin system
liddles syndrome
hypertension
high Na reab at collecting ducts eventhough aldosterone levels are low, too many Na in principle cell so reab too much Na - water follows = hypertension
pseudohypoaldosteronism
salt loss, water loss, hypotension but high aldosterone
loss of response to aldo, problem with mineralo receptor
renin-angiotensin
regulates body fluid, plasma Na, K
renin - released from juxtaglomerular apparatus (JGA)